{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-364210","form_type":"8-K","ticker":"SEPN","cik":"0001984086","company_name":"Septerna, Inc.","filed_at":"2026-08-25T12:15:05+00:00","discovered_at":"2026-08-25T12:20:00.497056+00:00","generated_at":"2026-08-25T12:20:05.322349+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Septerna appoints Rajiv Patni, M.D., as Chief Medical Officer, effective Aug 24, 2026","bullets":["Rajiv Patni, M.D., named CMO effective August 24, 2026; announcement press release dated August 25, 2026.","Patni brings 25+ years in biopharma; joins from Judo Bio where he was CEO, previously CRO at Reata.","He was CMO at Global Blood Therapeutics, Portola, Adamas, and Actelion; contributed to 10 regulatory approvals.","CEO Jeffrey Finer: Patni's experience will help advance Septerna's GPCR oral medicine pipeline."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-364210","json":"https://secwatch.observer/filing/0001193125-26-364210.json","markdown":"https://secwatch.observer/filing/0001193125-26-364210.md","text":"https://secwatch.observer/filing/0001193125-26-364210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1984086/000119312526364210/0001193125-26-364210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1984086/000119312526364210/d172697d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-25T12:20:05.322349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}